Faculty Recruit for Washington University Diabetic Cardiovascular Disease Center

华盛顿大学糖尿病心血管疾病中心招聘教师

基本信息

  • 批准号:
    7856409
  • 负责人:
  • 金额:
    $ 55.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This application seeks support from the National Heart, Lung & Blood Institute (NHLBI) through the NIH P30 mechanism (OD-09-005) for resources to recruit a newly independent assistant professor to the Diabetic Cardiovascular Disease Center (DCDC) at Washington University. DCDC is a recently established interdisciplinary research center that brings together scientists from diverse fields in work to advance our understanding of the mechanisms that contribute to the excess burden of myocardial and vascular disease in diabetics, and to rapidly translate new findings into development of diagnostic tools and therapeutic approaches. Under the auspices of DCDC, interdisciplinary teams of scientists are exploring the interactions between derangements in glucose and lipid metabolism and diabetic cardiac disease. One of the goals of ongoing projects is the development of new blood-based and imaging biomarkers. The outstanding individual we propose to recruit, Jeffrey Henderson, MD, PhD, will bring a new focus to the Center at the intersection between inflammation, infection and atherosclerosis. Dr. Henderson also has unique expertise in the use of sensitive mass spectrometry techniques for identification of urinary biomarkers. The resources of the P30, combined with the resources being provided by the Department of Medicine and DCDC and the thorough mentoring and career development plan described herein, will set the stage for the future success of this well-trained and highly promising individual in an area of high relevance to NHLBI. Diabetes is associated with serious cardiovascular complications including aggressive atherosclerosis and heart failure that is unrelated to atherosclerosis. The goal of the Diabetic Cardiovascular Disease Center is to develop new biomarkers for more effective diagnosis and treatment of this cardiovascular disease. This P30 program will support the recruitment to the Center of a well trained, promising young scientist.
描述(由申请人提供):本申请通过NIH P30机制(OD-09-005)寻求国家心肺血液研究所(NHLBI)的支持,以获得资源,为华盛顿大学的糖尿病心血管疾病中心(DCDC)招募新的独立助理教授。DCDC是一个最近成立的跨学科研究中心,汇集了来自不同领域的科学家,以促进我们对糖尿病患者心肌和血管疾病过度负担机制的理解,并将新发现快速转化为诊断工具和治疗方法的开发。在DCDC的主持下,跨学科的科学家团队正在探索葡萄糖和脂质代谢紊乱与糖尿病心脏病之间的相互作用。正在进行的项目的目标之一是开发新的血液和成像生物标志物。我们建议招募的杰出人士,杰弗里亨德森,医学博士,博士,将带来一个新的焦点,该中心在炎症,感染和动脉粥样硬化之间的交叉点。亨德森博士在使用灵敏的质谱技术鉴定尿液生物标志物方面也具有独特的专业知识。P30的资源,与医学部和DCDC提供的资源以及本文所述的全面指导和职业发展计划相结合,将为这位训练有素、前途无量的个人在与NHLBI高度相关的领域取得未来成功奠定基础。 糖尿病与严重的心血管并发症相关,包括侵袭性动脉粥样硬化和与动脉粥样硬化无关的心力衰竭。糖尿病心血管疾病中心的目标是开发新的生物标志物,以更有效地诊断和治疗这种心血管疾病。这个P30计划将支持招募一个训练有素,有前途的年轻科学家的中心。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JEAN E. SCHAFFER其他文献

JEAN E. SCHAFFER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JEAN E. SCHAFFER', 18)}}的其他基金

Lipotoxicity and Maintenance of Metabolic Health
脂毒性和代谢健康的维持
  • 批准号:
    10753221
  • 财政年份:
    2023
  • 资助金额:
    $ 55.52万
  • 项目类别:
Ribosome Heterogeneity as a Mechanism for Metabolic Regulation
核糖体异质性作为代谢调节机制
  • 批准号:
    10469691
  • 财政年份:
    2018
  • 资助金额:
    $ 55.52万
  • 项目类别:
Ribosome Heterogeneity as a Mechanism for Metabolic Regulation
核糖体异质性作为代谢调节机制
  • 批准号:
    10557973
  • 财政年份:
    2018
  • 资助金额:
    $ 55.52万
  • 项目类别:
Ribosome Heterogeneity as a Mechanism for Metabolic Regulation
核糖体异质性作为代谢调节机制
  • 批准号:
    10242772
  • 财政年份:
    2018
  • 资助金额:
    $ 55.52万
  • 项目类别:
Tissue Responses to Metabolic Stress
组织对代谢应激的反应
  • 批准号:
    9204834
  • 财政年份:
    2016
  • 资助金额:
    $ 55.52万
  • 项目类别:
Tissue Responses to Metabolic Stress
组织对代谢应激的反应
  • 批准号:
    9044213
  • 财政年份:
    2016
  • 资助金额:
    $ 55.52万
  • 项目类别:
Lipid Biomarkers for Diabetic Heart Disease
糖尿病心脏病的脂质生物标志物
  • 批准号:
    8805847
  • 财政年份:
    2012
  • 资助金额:
    $ 55.52万
  • 项目类别:
Lipid Biomarkers for Diabetic Heart Disease
糖尿病心脏病的脂质生物标志物
  • 批准号:
    8617296
  • 财政年份:
    2012
  • 资助金额:
    $ 55.52万
  • 项目类别:
Lipid Biomarkers for Diabetic Heart Disease
糖尿病心脏病的脂质生物标志物
  • 批准号:
    9015264
  • 财政年份:
    2012
  • 资助金额:
    $ 55.52万
  • 项目类别:
Lipid Biomarkers for Diabetic Heart Disease
糖尿病心脏病的脂质生物标志物
  • 批准号:
    8286484
  • 财政年份:
    2012
  • 资助金额:
    $ 55.52万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了